C-peptide Measurement may not be Necessary for Choosing a Treatment Modality in Type 2 Diabetes Mellitus: A Retrospective Analysis

Creative Commons License

Tazegul G., ÖĞÜT T. S., Bozoglan H., Dogan O., ÖZDEM S., SARI R., ...Daha Fazla

TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, cilt.21, sa.3, ss.68-71, 2017 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 21 Sayı: 3
  • Basım Tarihi: 2017
  • Doi Numarası: 10.25179/tjem.2017-56550
  • Dergi Adı: TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.68-71
  • Anahtar Kelimeler: C-peptide, insulin, type 2 diabetes mellitus, INSULIN-SECRETION RATES, FASTING PLASMA-GLUCOSE, COMBINATION, CLEARANCE
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Purpuse: C-peptide (CP), generated during the cleavage of proinsulin to form insulin, serves as a specific marker of insulin-secreting beta cell function. Since CP is utilized to assess the secretion of insulin, it may act as an indicator in the treatment algorithm of diabetes. The present retrospective study aimed to demonstrate whether patients previously diagnosed with type-2 diabetes (T2DM) and on antidiabetic treatment received the recommended CP-guided treatment mentioned in the current guideline.